Digital Health’s Game-changing Moment: Ultromics Receives FDA Designation for AI Cardiac Amyloidosis Tool
Ultromics, a UK-based AI company, has received FDA Breakthrough Device Designation for its EchoGo Amyloidosis platform, which analyses echocardiograms for signs of cardiac amyloidosis. The tool was developed with support from Janssen Biotech and…
Continue Reading
